• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

STAAR Surgical Co

Staar Surgical shakes up leadership structure

March 18, 2025 By Sean Whooley

Staar Surgical (Nasdaq:STAA) announced that it made a series of changes to realign its leadership structure to better address market needs. The shift atop the company comes around a month after the company laid off more than 100 workers amid challenging market conditions. Lake Forest, California–based Staar, a maker of Implantable Collamer lenses, created a […]

Filed Under: Business/Financial News, Implants, Optical/Ophthalmic, Vision Tagged With: Personnel Moves, Staar Surgical, STAAR Surgical Co

Staar Surgical rises on Street-beating Q2, raised guidance

August 10, 2021 By Sean Whooley

Staar Surgical (NSDQ:STAA) shares ticked up today on second-quarter results that topped the consensus forecast. The Lake Forest, Calif.-based implantable lens maker posted profits of $8.6 million, or 17¢ per share, on sales of $62.4 million for the three months ended July 2, 2021, for a massive bottom-line from over $1 million in the red […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Optical/Ophthalmic, Surgical, Wall Street Beat Tagged With: STAAR Surgical Co

Staar Surgical rises on 44% sales growth in Q1 result

May 6, 2021 By Danielle Kirsh

Staar Surgical (NSDQ:STAA) posted first-quarter results that beat the overall consensus on Wall Street. The Lake Forest, Calif.-based implantable eye lenses company yesterday reported profits of $4.99 million, or 10¢ per share, on sales of $50.75 million for the three months ended April 2, for a sales growth of 44.24% compared with Q1 2020. Adjusted to […]

Filed Under: MassDevice Earnings Roundup, Optical/Ophthalmic, Vision, Wall Street Beat Tagged With: STAAR Surgical Co

Staar Surgical slides despite Street-beating Q4 results

February 25, 2021 By Danielle Kirsh

Staar Surgical (NSDQ:STAA) posted fourth-quarter results yesterday that beat the consensus forecast on Wall Street. The Lake Forest, Calif.-based company reported profits of $3.3 million, or 7¢ per share, on sales of $46 million for the three months ended Jan. 1, 2021, for a bottom-line loss of -47.8% sales growth of 18.3% compared with Q4 2019. […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: STAAR Surgical Co

Staar Surgical launches presbyopia correcting lens

July 7, 2020 By Sean Whooley

Staar Surgical (NSDQ:STAA) announced today that it received CE Mark approval for its EVO Viva presbyiopia-correcting implantable Collamer lens (ICL). Lake Forest, Calif.-based Staar Surgical is launching the EVO Viva through select doctors in Spain, Germany and Belgium, initially, with broader availability set to follow across Europe and other markets recognizing the CE Mark, according to […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Regulatory/Compliance Tagged With: CE Mark, STAAR Surgical Co

Staar Surgical appoints CFO

July 6, 2020 By Danielle Kirsh

Staar Surgical (NSDQ:STAA) today said it has appointed Patrick Williams as chief financial officer, effective immediately. Williams will report directly to the president and CEO Caren Mason. His appointment is part of a planned transition following Deborah Andrews’s retirement. “STAAR is pleased to have a financial leader of Patrick’s caliber join the team at a time […]

Filed Under: Business/Financial News Tagged With: STAAR Surgical Co

Staar Surgical beats on earnings, meets revenue in Q4 results

February 27, 2020 By Danielle Kirsh

Staar Surgical (NSDQ:STAA) posted fourth-quarter results that beat the consensus forecast on Wall Street. The Monrovia, Calif.-based company reported profits of $6.4 million, or 14¢ per share, on sales of $38.9 million for the three months ended Jan. 3, 2020, for a bottom-line gain of 482% sales growth of 24.7% compared with Q4 2018. Adjusted to […]

Filed Under: Featured, Wall Street Beat Tagged With: STAAR Surgical Co

Staar Surgical wins supplemental lens approval for Evo, Evo+, Visian

January 13, 2020 By Sean Whooley

Staar Surgical (NSDQ:STAA) announced today that it won CE Mark approval for use of its three ICL lenses as supplemental lenses in post-cataract intraocular lenses surgery patients (pseudophakics). Lake Forest, Calif.-based Staar Surgical’s Evo, Evo+ and Visian lenses all earned the European approval. The Evo/Evo+ and Visian devices are implantable collamer lenses designed to treat myopia […]

Filed Under: Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: CE Mark, FDA, STAAR Surgical Co

FDA Oks Staar Surgical trial for Evo, Evo+ Visian lenses

August 27, 2019 By Sean Whooley

Staar Surgical (NSDQ:STAA) said today that the FDA approved a U.S. clinical trial of its Evo and Evo+ Visian lenses. Monrovia, Calif.-based Staar’s Evo/Evo+ devices are implantable collamer lenses designed to treat myopia and myopia with astigmatism. In May, the FDA’s Center for Devices & Radiological Health requested more data on the lenses, claiming Staar lacked […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: STAAR Surgical Co

Staar Surgical shares drop on FDA request for more data on EVO/EVO+ Visian lenses PMA bid

May 3, 2019 By Fink Densford

Staar Surgical (NSDQ:STAA) shares are down more than 10% after the company said it received a letter from the FDA’s Center for Devices and Radiological Health requesting more data for the premarket approval application supplement for its EVO/EVO+ Visian implantable collamer lenses for myopia and myopia with astigmatism. The federal watchdog said that the supplement lacked […]

Filed Under: Food & Drug Administration (FDA), Optical/Ophthalmic, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: STAAR Surgical Co

Staar Surgical inks deal with Iberian eye clinic group

February 28, 2019 By Fink Densford

Staar Surgical (NSDQ:STAA) said today it inked a strategic cooperation agreement with ophthalmology clinic group Vista Oftalmólogos to offer its Evo Visian implantable collamer lenses for patients suffering from nearsightedness. Vista Oftalmólogos is a 49-clinic group across Spain, France, Portugal and Morocco and employs more than 200 eye doctors and has 1,000 employees, Monrovia, Calif.-based Staar […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: STAAR Surgical Co

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy